Platelet-tolymphocyte ratio in patients with metastatic breast cancer treated with eribulin

被引：0
|
作者：
Shimada, Hiroko
Matsuura, Kazuo
Kohyama, Shunsuke
Asano, Aya
Ohara, Masahiro
Ishiguro, Hiroshi
Osaki, Akihiko
Saeki, Toshiaki
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-15-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-15-03
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Does the preoperative platelet-tolymphocyte ratio and neutrophil-tolymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
    ?brahim Mungan
    ?ilem Bay?nd?r Dicle
    ?erife Bekta?
    Sema Sar?
    Serdar Yamanyar
    Mine ?avu?
    Sema Turan
    Erdal Birol Bostanc?
    [J]. Military Medical Research, 2020, 7 (04) : 384 - 390
  • [2] Predictive value of neutrophil-to- lymphocyte and platelet-tolymphocyte ratios in patients with triple negative breast cancer treated with pembrolizumab
    Schreier, Ashley
    Zappasodi, Roberta
    Serganova, Inna
    Arcos, Laura Munoz
    Zhou, Xi Kathy
    Cristofanilli, Massimo
    Andreopolu, Eleni
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [3] Correction to: Does the preoperative platelet-tolymphocyte ratio and neutrophil-tolymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
    İbrahim Mungan
    Çilem Bayındır Dicle
    Şerife Bektaş
    Sema Sarı
    Serdar Yamanyar
    Mine Çavuş
    Sema Turan
    Erdal Birol Bostancı
    [J]. Military Medical Research, 7
  • [4] Does the preoperative platelet-tolymphocyte ratio and neutrophil-tolymphocyte ratio predict morbidity after gastrectomy for gastric cancer? (vol 7, 9, 2020)
    Mungan, Ibrahim
    Dicle, Cilem Bayindir
    Bektas, Serife
    Sari, Sema
    Yamanyar, Serdar
    cavus, Mine
    Turan, Sema
    Bostanci, Erdal Birol
    [J]. MILITARY MEDICAL RESEARCH, 2020, 7 (01)
  • [5] Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease
    Ahbap, Elbis
    Sakaci, Tamer
    Kara, Ekrem
    Sahutoglu, Tuncay
    Koc, Yener
    Basturk, Taner
    Sevinc, Mustafa
    Akgol, Cuneyt
    Kayalar, Arzu O.
    Ucar, Zuhal A.
    Bayraktar, Feyza
    Unsal, Abdulkadir
    [J]. CLINICAL NEPHROLOGY, 2016, 85 (04) : 199 - 208
  • [6] Outcome in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Cohort
    Rush, H.
    Khan, M.
    Li, S.
    Agorastos, A.
    Kristeleit, H.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (06) : E46 - E46
  • [7] TREATMENT WITH ERIBULIN (HALAVEN) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC BREAST CANCER
    Lynge, M.
    Liposits, G. I.
    Linnet, S.
    Langkjer, S. T.
    [J]. BREAST, 2013, 22 : S43 - S43
  • [8] Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer
    Rasmussen, Maja Lynge
    Liposits, Gabor
    Yogendram, Subethini
    Jensen, Anders Bonde
    Linnet, Soren
    Langkjer, Sven Tyge
    [J]. ACTA ONCOLOGICA, 2014, 53 (09) : 1275 - +
  • [9] Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin
    Barba, Maddalena
    Pizzuti, Laura
    Sperduti, Isabella
    Natoli, Clara
    Gamucci, Teresa
    Sergi, Domenico
    Di Lauro, Luigi
    Moscetti, Luca
    Izzo, Fiorentino
    Rinaldi, Massimo
    Mentuccia, Lucia
    Vaccaro, Angela
    Iezzi, Laura
    Grassadonia, Antonino
    Michelotti, Andrea
    Landucci, Elisabetta
    Perracchio, Letizia
    Pescarmona, Edoardo
    Di Filippo, Franco
    Giordano, Antonio
    Maugeri-Sacca, Marcello
    Vici, Patrizia
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (05) : 986 - 991
  • [10] Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin
    Oba, Takaaki
    Maeno, Kazuma
    Ono, Mayu
    Ito, Tokiko
    Kanai, Toshiharu
    Ito, Ken-ichi
    [J]. ANTICANCER RESEARCH, 2021, 41 (01) : 445 - 452
12345